International Agency for Research on Cancer

iarc.who.int

Total trials

30

Active

13

Phase 3

2

Total enrollment

494,738

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 5 of 5 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Triple therapy1
quadrivalent HPV vaccine1
HPV vaccine1
HAV vaccine1
The study being observational in nature, there is no intervention. The investigators will only collect cervical samples from married women within a specified age range at different intervals.1

Next readouts

  • 2026-10-30
  • 2027-06-30
  • 2028-12-01
  • 2033-12

Top conditions

  • Breast Cancer6
  • Cervical Cancer6
  • Oral Cancer3
  • Colorectal Cancer2
  • HPV Infection2
  • Cervical Precancer1
  • Carcinoma in Situ1
  • Cervical Neoplasm1

Frequently asked questions about International Agency for Research on Cancer

How many clinical trials does International Agency for Research on Cancer have on ClinicalTrials.gov?
International Agency for Research on Cancer is listed as the lead sponsor on 30 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
How many of International Agency for Research on Cancer's trials are in Phase 3?
2 of International Agency for Research on Cancer's trials are in Phase 3, spread across 5 active drug programs.
What therapeutic areas does International Agency for Research on Cancer focus on?
International Agency for Research on Cancer's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Cervical Cancer, Oral Cancer, Colorectal Cancer, HPV Infection.
When are International Agency for Research on Cancer's next clinical trial readouts?
International Agency for Research on Cancer has 4 upcoming primary-completion readouts tracked here; the soonest is “Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India”, expected around 2026-10-30.